Product Center
Products Center
Fourth Mount Tai Medical Forum Concludes Jiuhua Huayuan Pharmaceutical Secures Four Prestigious Honors
Release time:
2025-11-18 14:18
Source:
JINAN, China – On November 9–10, 2025, the Fourth Mount Tai Medical Forum and the 2024–2025 Pharmaceutical Industry Information Release Conference, hosted by the All-China Federation of Industry and Commerce’s Pharmaceutical Industry Chamber of Commerce, was grandly held in Jinan, Shandong. Leading enterprises, scientific research institutions, and expert representatives from across the nation’s pharmaceutical industry gathered to explore new trends in high-quality development.
Jiuhua Huayuan Pharmaceutical, demonstrating outstanding performance in compliance, innovation, and industrial chain development, was honored with four prestigious awards:
- 2024–2025 China Pharmaceutical Industry Compliant and Trustworthy Enterprise
- Top 50 Enterprises in Growth Rate in China’s Pharmaceutical Industry
- Emerging Leader in China’s Pharmaceutical Industry (Guan Yueqin, Chairman of Jiuhua Huayuan Pharmaceutical)
- China Outstanding Genuine Regional Traditional Chinese Medicine Cultivation Demonstration Base
These accolades affirm the company’s achievements in technological innovation and standardized management under its corporate philosophy of "Steadfast Loyalty, Innovative Milestones." They also reflect Jiuhua Huayuan’s comprehensive strength in advancing the modernization of traditional Chinese medicine (TCM), promoting green and market-oriented development of the industrial chain.
As a pharmaceutical enterprise nurtured in Anhui Province, Jiuhua Huayuan Pharmaceutical has always adhered to its founding mission of "Serving and Contributing to Human Health." The company focuses on a dual-pillar strategy of botanical drugs and chemical pharmaceuticals, with deep expertise in key areas such as plant-based anti-infectives, cardiovascular and cerebrovascular diseases, and endocrinology. By continuously increasing investment in R&D and innovation, improving intelligent production systems, and strictly controlling quality standards, Jiuhua Huayuan empowers market expansion with professional services, driving steady growth and establishing itself as a benchmark for high-quality development in the pharmaceutical industry.
Carrying these honors forward with a sense of mission, and bolstered by industry trust and market recognition, Jiuhua Huayuan Pharmaceutical will use this recognition as a new starting point. The company will continue to strengthen its foundation in compliant and ethical operations, invigorate development through innovation, and deepen industrial collaboration and academic partnerships. It remains committed to providing safe, effective, and high-quality medicines and health solutions to society, contributing further to public health and the high-quality development of China’s pharmaceutical industry.
Previous Page
